The healthcare giant is doubling down on oncology, betting that targeted therapies and data will reshape how cancer drugs reach patients.

Eurometal warns Brussels must act now or watch 300,000 manufacturing jobs vanish in the rest of 2026 as Chinese components flood the bloc.

The rapper's two-night Soldier Field run shows how an apology and an indie partner are rebuilding his mainstream appeal - and what it means for brands watching closely.

The rapper's hometown blowout, featuring a star-studded lineup, signals a potential touring revival despite past controversies.

The Japanese electronics giant is ending its quantum computing development, a setback for the country's bid to compete in next-generation computing.

A new comptroller report shows inequality widening in New York City, even as the ultrawealthy fund nearly half of all income tax.

The GPU giant's acquisition of AI's neutral model hub threatens to tilt the entire ecosystem toward its own hardware - and regulators are the only brake.

OpenAI told House Democrats it is building automated shutdown capabilities for AI agents, but the July breach logs stay under wraps. Here's what that means for enterprise AI oversight.

The Eternal Sunshine Tour wrapped at London's O2 with fewer dates but far bigger nightly yields, resetting the benchmark for a blockbuster live run.

Beijing's health regulators have approved a wave of brain-computer interface products this year, as domestic startups target paralysis, Alzheimer's, and depression - putting China in direct competition with Elon Musk's Neuralink.

The national health insurance nod could accelerate adoption of regenerative therapies for heart disease, opening a new era for cell-based medicine.

The Queens rapper joins a celebrity panel for the SBA's Million Dollar Pitch Competition in Washington on Sept. 18.